Adrian A. Suarez - Concepedia

Author

Adrian A. Suarez

Also Known As

A A Suarez, A A Suárez, A Suarez, A Suárez, A. Suarez, A.A. Suarez, Adrian A Suarez, Adrian A. Suarez, Adrian Suarez, Adrian A. Suarez

141

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University The Ohio State University Wexner Medical Center The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Washington University in St. Louis Johns Hopkins University

About

Adrian A. Suarez is an author at The Ohio State University specializing in medicine, obstetrics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	23	1.4K
2	Cell Biology	4	4	490
3	Public Health	1	1	24
4	Social Sciences	1	1	10
5	Endocrinology	1	1	99

Adrian A. Suarez

Publications

Citations

H-Index

Page 1

	Year	Citations
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins Kalpana Deepa Priya Dorayappan, Ross Wanner, John Wallbillich, Oncogene Novel MechanismSignaling PathwayHypoxia-induced ExosomesMedicineStat3/rab Proteins	2018	297
Polymerase ɛ (<scp><i>POLE</i></scp>) mutations in endometrial cancer: Clinical outcomes and implications for <scp>L</scp>ynch syndrome testing Caroline C. Billingsley, David E. Cohn, David G. Mutch, Cancer	2014	176
Bokhman Redux: Endometrial cancer “types” in the 21st century Adrian A. Suarez, Ashley S. Felix, David E. Cohn Gynecologic Oncology Tumoral PathologyMedicineGynecologyBokhman ReduxOncology	2016	165
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer Casey Cosgrove, David Tritchler, David E. Cohn, Gynecologic Oncology Risk PredictionMedicineEndometrioid Endometrial CancerPathologyGynecology	2017	131
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival Casey Cosgrove, David E. Cohn, Heather Hampel, Gynecologic Oncology Epigenetic SilencingMedicineEpigenetic ChangeGynecologyPathology	2017	123
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target U. Saini, Srikanth I. Naidu, Adam C. ElNaggar, Oncogene Oncogenic AgentMedicinePromotes InvasionTumor SuppressorStat3 Expression	2016	112
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer Floor Backes, Christopher J. Walker, Paul J. Goodfellow, Gynecologic Oncology Hormonal ReceptorUterine ReceptivityEndometrioid Endometrial CancerGynecologyEndocrinology	2016	99
Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer Floor Backes, Marino E. Leon, Iouri Ivanov, Gynecologic Oncology Primary Endometrial CancerGenome InstabilityMedicineGynecologyPathology	2009	75
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739) Floor Backes, David Cohen, Ritu Salani, Gynecologic Oncology Robotic SentinelGynecological SurgeryMedicineIsosulfane BlueGynecology	2019	75
Mismatch repair deficiency identifies patients with high‐intermediate–risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker Floor Backes, Jennifer Haag, Casey Cosgrove, Cancer	2018	65

Page 1